Chronic Obstructive Pulmonary Disease Exacerbations. Chronic obstructive pulmonary disease with (acute) exacerbation
Conditions
Interventions
Intervention 1: Intervention group: Receiving routine services and prescribing 2.5 cc of salbutamol-ipratropium inhalation solution with a dose of 2.5 mg of salbutamol, 0.5 mg of ipratropium and 20 mg
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: Definite diagnosis of exacerbation COPD disease Age range of 20-65 years Stable vital signs Controlled and constant medication regimen during the study
Exclusion criteria
Exclusion criteria: Moderate to severe heart failure Digestive problems such as severe nausea and vomiting Cancers of the respiratory tract Chronic kidney or liver disease Surgery of the respiratory system over the past year Pregnancy and breastfeeding Allergy to sulfated drugs Withdrawal from participating
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of symptoms of cough, sputum, shortness of breath, restriction of daily activities, insomnia, premature fatigue during activity. Timepoint: 5 days. Method of measurement: CAT Scoring.;Duration of symptoms (disease). Timepoint: 5 days. Method of measurement: Questionnaire.;Chronic Obstructive Pulmonary Disease Exacerbation. Timepoint: 5 days. Method of measurement: Examination and radiology.;Number of years since diagnosis. Timepoint: 5 days. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahdi Behi
Shahid Beheshti University of Medical Sciences
Outcome results
None listed